相关实验视频
Updated: Feb 14, 2026

10:52
Precise Phage Mutagenesis with NgTET-Assisted CRISPR-Cas Systems
Published on: October 14, 2025
694
通过基于合成菌体的CRISPR-Cas传递系统有针对性地消除黄金葡萄球菌乳腺炎感染
Nahiara Garmendia-Antoñana1, Pedro Dorado-Morales1,2, Carmen Gil1
1Laboratory of Microbial Pathogenesis, Navarrabiomed-Universidad Pública de Navarra (UPNA)-Hospital Universitario de Navarra (HUN), IdiSNA, Irunlarrea 3, Pamplona, Navarra, Spain.
NPJ biofilms and microbiomes
|February 12, 2026
概括
工程化菌群岛 (ePICI) 提供CRISPR-Cas9来杀死金黄色葡萄球菌,为牲畜乳腺炎提供了抗生素的有希望的替代品. 生物膜组成会影响疗效,但ePICI甚至对抗性菌株也表现出有效性.
科学领域:
- 微生物学 微生物学
- 基因工程是一种基因工程.
- 兽医医学 兽医医学 兽医医学
背景情况:
- 黄金葡萄球菌 (Staphylococcus aureus) 在牲畜中造成重大经济损失,特别是通过乳腺炎,由于抗生素耐药性增加,需要新的治疗策略.
- 目前对黄金杆菌乳腺炎的治疗通常涉及长时间的抗生素疗程,这有助于产生耐药菌株.
- 基于菌体的疗法提供了一个潜在的替代方案,但它们的有效性可能受到细菌因素的影响,例如生物膜的形成.
研究的目的:
- 设计非复制性菌体诱导性染色体岛屿 (ePICI) 以提供CRISPR-Cas9基因编辑模块,以向S. aureus中的小RNA基因.
- 评估工程化ePICI的杀菌活性,宿主范围和生物膜依赖的疗效.
- 在小鼠乳腺炎模型中评估ePICI的体内疗效,特别是对产生Bap的金黄色菌株.
主要方法:
- 携带CRISPR-Cas9模块的工程化ePICI针对重要的小RNA基因.
- 评估了ePICI对S. aureus菌株的杀菌活性,这些菌株具有不同的生物膜组成 (Bap介导与PIA/PNAG介导).
- 与父母菌体相比,评估了ePICI的宿主范围,并在小鼠乳腺炎模型中测试了有效性.
主要成果:
- 设计的ePICI显示出对S. aureus没有染色体融合的杀菌活性,并显示出扩大了宿主范围.
- 生物膜矩阵成分显著影响了ePICI的疗效;Bap介导的生物膜提供了强大的保护,而基于PIA/PNAG的生物膜没有.
- 尽管Bap在体外进行了保护,但ePICI在小鼠乳腺炎模型中实现了与菌素相当的杀菌效果.
结论:
- 非复制性EPICI是一种有希望的替代方案,用于治疗局部S. aureus感染,如乳腺炎.
- 细菌生物膜的组成是影响菌体传递CRISPR-Cas系统疗效的关键因素.
- 在体外生物膜保护并不总是预测体内性能,强调需要进行全面的疗效测试.
相关概念视频
CRISPR and crRNAs
19.2K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.2K
Modified-Release Drug Delivery Systems: Site-Targeted
4
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
4
Site-Targeted Drug Delivery Systems: Polymeric Carriers
2
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
2
CRISPR
58.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.0K
Transdermal Drug Delivery Systems
4
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
4
Ophthalmic Drug Delivery Systems
4
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
4

